Original paper
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
Abstract
Liver transplant (LT) recipients or other immunocompromised patients were not included in the registration trials studying the efficacy of vaccines against SARS-CoV-2. Although the clinical efficacy of COVID-19 vaccines in immunocompromised patients is unknown, many societies have recommended vaccination of this highly vulnerable patient population.In this prospective study, we determined antibody responses to spike protein, 4 weeks after the...
Paper Details
Title
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
Published Date
Dec 1, 2021
Journal
Volume
75
Issue
6
Pages
1434 - 1439
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History